Abstract

Summary

The post-illumination pupil response (PIPR), driven by melanopsin-expressing ipRGCs, can serve as a non-invasive clinical tool to assess retinal and optic nerve integrity, particularly in glaucoma patients. Lighting designers and clinicians can leverage 470nm (blue) light stimuli to evaluate ipRGC function, with implications for monitoring diseases that affect both visual and non-visual light-processing pathways.
Abstract

Key Findings

  • All normal subjects displayed a measurable PIPR in response to a 10-second 470nm stimulus, with a mean PIPR of 1.4 mm pupil constriction post-illumination.
  • PIPR was significantly reduced in glaucomatous optic neuropathy (GON) patients compared to age-matched controls (p<0.05).
  • Magnitude of PIPR loss correlated with severity of visual field loss as measured by mean deviation (MD) in GON patients.
  • PIPR was not significantly affected by subject age, race, or gender; baseline pupil diameter was the only significant factor influencing PIPR magnitude in normal subjects.
Categories

Categories

Eye Health & Vision: Examines the post-illumination pupil response (PIPR) as a clinical marker for glaucomatous optic neuropathy and retinal health.
The Science of Light: Investigates the melanopsin-driven ipRGC contribution to the pupillary light reflex using a 470nm stimulus, advancing understanding of non-visual photoreception.
Authors

Author(s)

L Kankipati
Publication Date

Publication Year

2009
Citations

Number of Citations

1
View more publications